Doug Simonetto, MD

Mayo Clinic Gastroenterology & Hepatology @MayoClinicGIHep · Oct 15

Please join us in congratulating our own @SaqrAlsakarneh on 1st-place finish in the 2026 ACG EndoTitans Challenge!

This national competition brings together trainees from across the country to showcase their endoscopic skill, precision, and technical expertise and Mayo Clinic represented by Dr. Saqr Alsakarneh, rose to the top! 🎉

We are incredibly proud of this outstanding achievement and the dedication it represents. Help us celebrate this well-deserved win of our skilled fellows! 👏
#ACG2026 #GITwitter #Endoscopy”

View quoted post on X

Amir Seid @amirs_umn · May 4

Great #DDW026 and of course a great team from @MayoClinicGIHep

View quoted post on X

pubmed.ncbi.nlm.nih.gov An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in... F-652 is safe in doses up to 45 μg/kg and associated with a high rate of improvement as determined by Lille and MELD scores, reductions in markers of inflammation and increases in markers of hepatic...

AlcHepNet @AlcHepNet · Feb 25

First post + big milestone! 🎉

The ITAALD Trial has officially enrolled its first patient in January. Huge thanks to our investigators and site teams for making this happen.

We’re just getting started. #ITAALD #ClinicalTrials

View quoted post on X

Mayo Clinic Verified account @MayoClinic · Dec 17, 2025

Advanced liver disease is often silent. Mayo Clinic researchers built an AI model that helps doctors detect it earlier — even without symptoms — so care can begin sooner.

Read more:

View quoted post on X

Mayo Clinic Gastroenterology & Hepatology @MayoClinicGIHep · Dec 4, 2025

A huge welcome to our 2026 GIH fellowship class! 🎉

We’re proud to bring together this remarkable group of trainees committed to advancing patient care, research, and innovation in GI and Hepatology. The future is bright with you all on our team! 🌟

#GIMatch #MedicalEducation #FutureofGI #Match2026

View quoted post on X